2025-2031 Global Sevoflurane Anesthesia Drugs Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Sevoflurane Anesthesia Drugs Industry Research & Trends Analysis Report

2025-2031 Global Sevoflurane Anesthesia Drugs Industry Research & Trends Analysis Report

Publication Date: 2025-11-19
Report Id: 2808344
Industry: Pharma & Healthcare
Report Page: 123
Chart: 128

PDF Download

Publication Date: 2025-11-19
Report Id: 2808344
Industry: Pharma & Healthcare
Report Page: 123
Chart: 128

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Sevoflurane Anesthesia Drugs Definition
1.2 Global Sevoflurane Anesthesia Drugs Market Size and Forecast
1.2.1 By Revenue, Global Sevoflurane Anesthesia Drugs Market Size, 2020-2031
1.2.2 By Sales Volume, Global Sevoflurane Anesthesia Drugs Market Size, 2020-2031
1.2.3 Global Sevoflurane Anesthesia Drugs Price Trend, 2020-2031
1.3 China Sevoflurane Anesthesia Drugs Market Size and Forecast
1.3.1 By Revenue, China Sevoflurane Anesthesia Drugs Market Size, 2020-2031
1.3.2 By Sales Volume, China Sevoflurane Anesthesia Drugs Market Size, 2020-2031
1.3.3 China Sevoflurane Anesthesia Drugs Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Sevoflurane Anesthesia Drugs Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Sevoflurane Anesthesia Drugs Share in Global Market, 2020-2031
1.4.3 Sevoflurane Anesthesia Drugs Market Size: China VS Global, 2020-2031
1.5 Sevoflurane Anesthesia Drugs Market Dynamics
1.5.1 Sevoflurane Anesthesia Drugs Market Drivers
1.5.2 Sevoflurane Anesthesia Drugs Market Restraints
1.5.3 Sevoflurane Anesthesia Drugs Industry Trends
1.5.4 Sevoflurane Anesthesia Drugs Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Sevoflurane Anesthesia Drugs Revenue by Company, 2020-2025
2.2 Global Sevoflurane Anesthesia Drugs Sales Volume by Company, 2020-2025
2.3 Global Sevoflurane Anesthesia Drugs Price by Company, 2020-2025
2.4 Global Sevoflurane Anesthesia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Sevoflurane Anesthesia Drugs Concentration Ratio
2.6 Global Sevoflurane Anesthesia Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Sevoflurane Anesthesia Drugs Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Sevoflurane Anesthesia Drugs Revenue by Company, 2020-2025
3.2 China Sevoflurane Anesthesia Drugs Sales Volume by Company, 2020-2025
3.3 China Sevoflurane Anesthesia Drugs Sevoflurane Anesthesia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Sevoflurane Anesthesia Drugs Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Sevoflurane Anesthesia Drugs Domestic VS Export
3.6 China Market, Sevoflurane Anesthesia Drugs Import & Export
3.6.1 China Market, Sevoflurane Anesthesia Drugs Import & Export, 2020-2031
3.6.2 China Sevoflurane Anesthesia Drugs Import & Export Trends
3.6.3 Main Sources of China Sevoflurane Anesthesia Drugs Import
3.6.4 Export Destination of China Sevoflurane Anesthesia Drugs

4 Sevoflurane Anesthesia Drugs Production by Region
4.1 Global Sevoflurane Anesthesia Drugs Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Sevoflurane Anesthesia Drugs Manufacturers
4.3 Global Major Manufacturers, Sevoflurane Anesthesia Drugs Capacity Expansion and Future Plans
4.4 Global Sevoflurane Anesthesia Drugs Capacity by Region
4.5 Global Sevoflurane Anesthesia Drugs Production by Region
4.5.1 Global Sevoflurane Anesthesia Drugs Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Sevoflurane Anesthesia Drugs Production by Region, 2020-2025
4.5.3 Global Sevoflurane Anesthesia Drugs Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Sevoflurane Anesthesia Drugs Industry Chain
5.2 Sevoflurane Anesthesia Drugs Upstream Analysis
5.2.1 Sevoflurane Anesthesia Drugs Core Raw Materials
5.2.2 Main Manufacturers of Sevoflurane Anesthesia Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Sevoflurane Anesthesia Drugs Production Mode
5.6 Sevoflurane Anesthesia Drugs Procurement Model
5.7 Sevoflurane Anesthesia Drugs Industry Sales Model and Sales Channels
5.7.1 Sevoflurane Anesthesia Drugs Sales Model
5.7.2 Sevoflurane Anesthesia Drugs Typical Distributors

6 Sights by Product Type
6.1 Sevoflurane Anesthesia Drugs Classification
6.1.1 250ml/Bottle
6.1.2 120ml/Bottle
6.1.3 Other
6.2 by Type, Global Sevoflurane Anesthesia Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Sevoflurane Anesthesia Drugs Revenue, 2020-2031
6.4 by Type, Global Sevoflurane Anesthesia Drugs Sales Volume, 2020-2031
6.5 by Type, Global Sevoflurane Anesthesia Drugs Price, 2020-2031

7 Sights by Application
7.1 Sevoflurane Anesthesia Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 by Application, Global Sevoflurane Anesthesia Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Sevoflurane Anesthesia Drugs Revenue, 2020-2031
7.4 by Application, Global Sevoflurane Anesthesia Drugs Sales Volume, 2020-2031
7.5 by Application, Global Sevoflurane Anesthesia Drugs Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Sevoflurane Anesthesia Drugs Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Sevoflurane Anesthesia Drugs Revenue, 2020-2031
8.3 By Region, Global Sevoflurane Anesthesia Drugs Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Sevoflurane Anesthesia Drugs Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Sevoflurane Anesthesia Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Sevoflurane Anesthesia Drugs Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Sevoflurane Anesthesia Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Sevoflurane Anesthesia Drugs Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Sevoflurane Anesthesia Drugs Market Size Market Share
8.7 South America
8.7.1 South AmericaSevoflurane Anesthesia Drugs Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Sevoflurane Anesthesia Drugs Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Sevoflurane Anesthesia Drugs Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Sevoflurane Anesthesia Drugs Revenue, 2020-2031
9.3 By Country, Global Sevoflurane Anesthesia Drugs Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.4.2 By Company, United States Sevoflurane Anesthesia Drugs Sales Volume Market Share, 2024
9.4.3 by Type, United States Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.5.2 By Company, Europe Sevoflurane Anesthesia Drugs Sales Volume Market Share, 2024
9.5.3 by Type, Europe Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.6.2 By Company, China Sevoflurane Anesthesia Drugs Sales Volume Market Share, 2024
9.6.3 by Type, China Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.7.2 By Company, Japan Sevoflurane Anesthesia Drugs Market Share, 2024
9.7.3 by Type, Japan Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.8.2 By Company, South Korea Sevoflurane Anesthesia Drugs Market Share, 2024
9.8.3 by Type, South Korea Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Sevoflurane Anesthesia Drugs Market Share, 2024
9.9.3 by Type, Southeast Asia Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.10.2 By Company, India Sevoflurane Anesthesia Drugs Market Share, 2024
9.10.3 by Type, India Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Sevoflurane Anesthesia Drugs Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Sevoflurane Anesthesia Drugs Market Share, 2024
9.11.3 by Type, Middle East & Africa Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Sevoflurane Anesthesia Drugs Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Hengrui
10.1.1 Hengrui Company Information, Head Office, Market Area, and Industry Position
10.1.2 Hengrui Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.1.3 Hengrui Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Hengrui Company Profile and Main Business
10.1.5 Hengrui Recent Developments
10.2 Baxter
10.2.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.2.2 Baxter Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.2.3 Baxter Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Baxter Company Profile and Main Business
10.2.5 Baxter Recent Developments
10.3 Maruishi
10.3.1 Maruishi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Maruishi Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.3.3 Maruishi Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Maruishi Company Profile and Main Business
10.3.5 Maruishi Recent Developments
10.4 AbbVie
10.4.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
10.4.2 AbbVie Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.4.3 AbbVie Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 AbbVie Company Profile and Main Business
10.4.5 AbbVie Recent Developments
10.5 Piramal
10.5.1 Piramal Company Information, Head Office, Market Area, and Industry Position
10.5.2 Piramal Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.5.3 Piramal Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Piramal Company Profile and Main Business
10.5.5 Piramal Recent Developments
10.6 Hebei Yipin Pharmaceutical
10.6.1 Hebei Yipin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.6.3 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Hebei Yipin Pharmaceutical Company Profile and Main Business
10.6.5 Hebei Yipin Pharmaceutical Recent Developments
10.7 PT Novell Pharmaceutical
10.7.1 PT Novell Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.7.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 PT Novell Pharmaceutical Company Profile and Main Business
10.7.5 PT Novell Pharmaceutical Recent Developments
10.8 Lunan Pharma
10.8.1 Lunan Pharma Company Information, Head Office, Market Area, and Industry Position
10.8.2 Lunan Pharma Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.8.3 Lunan Pharma Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Lunan Pharma Company Profile and Main Business
10.8.5 Lunan Pharma Recent Developments
10.9 Hana Pharm
10.9.1 Hana Pharm Company Information, Head Office, Market Area, and Industry Position
10.9.2 Hana Pharm Sevoflurane Anesthesia Drugs Models, Specifications, and Application
10.9.3 Hana Pharm Sevoflurane Anesthesia Drugs Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Hana Pharm Company Profile and Main Business
10.9.5 Hana Pharm Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Sevoflurane Anesthesia Drugs should grow from US$ 1342 million in 2024 to US$ 1753 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Sevoflurane Anesthesia Drugs

According to YH Research, the global market for Sevoflurane Anesthesia Drugs should grow from US$ 1342 million in 2024 to US$ 1753 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.

The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.

One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

China is the largest consumption place, with a revenue market share nearly 40.71% in 2023. Following China, North Americas is the second largest consumption place with the revenue market share of 25.08%.
The global key manufacturers of Sevoflurane Anesthesia Drugs include Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, Hana Pharm, Hebei Yipin Pharmaceutical, etc. In 2023, the global top five players had a share approximately 91.92% in terms of revenue.

This report aims to provide a comprehensive study of the global market for Sevoflurane Anesthesia Drugs.
Report Highlights:
(1) Global Sevoflurane Anesthesia Drugs market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Sevoflurane Anesthesia Drugs market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Sevoflurane Anesthesia Drugs market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Sevoflurane Anesthesia Drugs segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Sevoflurane Anesthesia Drugs segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Sevoflurane Anesthesia Drugs, capacity, production and trends.

(7) Sevoflurane Anesthesia Drugs industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
250ml/Bottle
120ml/Bottle
Other

Market segment by Application, can be divided into
Hospital
Clinic
Other

Market segment by players, this report covers
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Hebei Yipin Pharmaceutical
PT Novell Pharmaceutical
Lunan Pharma
Hana Pharm